The Royal Devon and Exeter Hospital, is a large teaching hospital situated in Exeter, Devon, England. The hospital has two sites, situated in Wonford and Heavitree, Exeter, and is part of the Royal Devon and Exeter NHS Foundation Trust.

During the past decade, Royal Devon & Exeter Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 4 clinical trials were completed, i.e. on average, 17.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Devon & Exeter Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Bayer" with 2 trials sponsored, "Ipsen" with 2 trials sponsored, "ApoPharma" with 1 trials sponsored and "Cardiff University" with 1 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Devon & Exeter Hospital" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "University of Birmingham" with 2 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Royal Devon & Exeter Hospital" are "Abscess Anorectal" (1 trials), "Abscess; Anus" (1 trials), "Accelerated Phase Chronic Myelogenous Leukemia" (1 trials), "Achilles Tendon Rupture" (1 trials) and "Acute Myeloid Leukaemia" (1 trials). Many other conditions were trialed in "Royal Devon & Exeter Hospital" in a lesser frequency.

Most popular intervention types in "Royal Devon & Exeter Hospital" are "Drug" (18 trials), "Other" (5 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "Vincristine" (3 trials) and "Prednisolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Devon & Exeter Hospital" are 28 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Devon & Exeter Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Royal Devon & Exeter Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Devon & Exeter Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".